EKF Diagnostics (LON:EKF – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported GBX 0.54 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%.
EKF Diagnostics Price Performance
LON:EKF traded down GBX 0.60 during trading hours on Wednesday, hitting GBX 25. 191,987 shares of the stock traded hands, compared to its average volume of 326,429. The company has a market cap of £107.04 million, a price-to-earnings ratio of 53.19 and a beta of 0.50. EKF Diagnostics has a 1 year low of GBX 22 and a 1 year high of GBX 31.70. The stock has a 50 day moving average price of GBX 25.45 and a 200 day moving average price of GBX 25.51. The company has a quick ratio of 1.77, a current ratio of 4.16 and a debt-to-equity ratio of 2.01.
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Featured Stories
- Five stocks we like better than EKF Diagnostics
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
